Using epigenetic aging data to drive health behavior change Authors: Phillip A Williford, Dana Howell, Esther Dupont-Versteegden Published: 2026 ABSTRACT AbstractObjectiveThis conceptual article proposes a patient-counseling framework that integrates epigenetic aging measures into the Transtheoretical Model (TTM) to support personalized health behavior change.MethodsWe developed a conceptual model by mapping potentially motivational properties of epigenetic age feedback, including its interpretability, biological science, and modifiability, onto stage-specific behavior-change processes within the TTM.ResultsThe proposed model describes how epigenetic age feedback may be introduced differently across precontemplation, contemplation, preparation, action, maintenance, and relapse phases. Rather than functioning as a stand-alone motivator, epigenetic age is positioned as a complementary tool alongside established approaches such as motivational interviewing, wearable monitoring, and conventional risk assessment. This framework also outlines how repeat measurement may be used selectively to reinforce progress, re-engage patients after slippage, and personalize counseling around behaviors such as physical activity, sleep, nutrition, and stress management.ConclusionIntegrating epigenetic age data into stage-matched counseling offers a plausible, patient-centered approach to behavior change, but it remains conceptual and requires empirical evaluation of feasibility, acceptability, and communication effects.InnovationThis article frames epigenetic age from a research biomarker into a stage-specific patient education tool and proposes a modified TTM in which repeat biological age assessment is used as a targeted relapse-prevention and re-engagement strategy.Keywords: Epigenetic age, Biological aging, Lifestyle behavior change, Transtheoretical model, Personalized health feedback, Preventive healthcare Introduction Epigenetics is the study of how active gene expression changes in response to stimulus without altering the DNA sequence. [1] Epigenetic modifications like DNA methylation (DNAm) control gene expression and are key to understanding chronic disease and aging, and the epigenome's flexibility and response to lifestyle choices make it an excellent target for healthspan improvement. [1], [2] Epigenetic clocks leverage these DNAm patterns to estimate an individual's biological age. [3], [4], [5] While initial models primarily predicted chronological age, newer, second-generation clocks (e.g., PhenoAge, GrimAge, DunedinPACE [6]) incorporate health and clinical biomarkers, predicting physiologically relevant measures like mortality risk and the pace of aging. [5], [7] This ability to integrate multiple system-level signals into a single summary metric may make epigenetic clocks clinically meaningful, particularly when they are interpreted alongside established indicators such as blood pressure, laboratory markers, functional measures, and composite risk scores rather than in isolation. Given that lifestyle factors drive approximately 30% of health outcomes [8], these dynamic clocks offer a powerful metric for tracking progress in lifestyle medicine. The Transtheoretical Model (TTM) is a cyclical framework explaining behavior change through stages: precontemplation, contemplation, preparation, action, maintenance, and relapse. [9], [10], [11], [12], [13] This paper proposes integrating personalized epigenetic age data into the TTM to maximize motivation and adherence, and to utilize repeated measurements to prevent backsliding. The present framework is intended not only as a theoretical integration of biomarker science and behavior change theory, but also as a practical model for communicating complex biological information in a stage-appropriate, behaviorally actionable manner. Methods Since this paper proposes a theoretical model rather than reporting empirical data, the methods describe the conceptual approach used for integrating a novel biomarker into an established behavioral framework. This framework was also developed with attention to patient education and clinician-patient communication. Accordingly, the model emphasizes how epigenetic age information might be explained, contextualized, and paired with stage-appropriate counseling strategies. Selection of core framework The Transtheoretical Model (TTM) was selected as the foundational framework due to its established utility in guiding and measuring behavior change across diverse populations and health goals. [9] Its cyclical progression through stages—from precontemplation to maintenance and relapse—provides a structural map onto which targeted interventions can be applied, making it ideal for incorporating a personalized, stage-specific motivator. Conceptual integration strategy The integration strategy focused on identifying the unique properties of epigenetic clocks that could address the TTM's main challenges, particularly motivating individuals in the early stages and preventing relapse during the maintenance phase. Key properties identified were the dynamism (responsiveness to lifestyle changes) of epigenetic age data and their capacity to generate mental inconsistency (the gap between chronological and biological age). This led to the design of the core intervention: leveraging the initial biological age result to transition individuals from Preparation to Action, and using repeated, “just-in-time” re-measurement to create a novel feedback loop that actively targets and minimizes the risk of relapse. Results The benefit of epigenetic clocks in promoting behavior change Epigenetic clocks may offer distinctive motivational value, but they should not be viewed as replacements for established behavioral and clinical tools. Unlike fixed genetic risk scores, epigenetic aging measures are potentially modifiable and therefore may be more compatible with behavior change and counseling. [14] They also summarize multisystem biological information in a single metric, which may be easier for some patients to understand than a panel of separate risk indicators. [4], [5] At the same time, composite risk scores, wearable device outputs, and physical performance-based measures provide important complementary information. In practice, wearable and performance metrics may be especially useful for frequent, behavior-proximal feedback, whereas epigenetic age may function better as an intermittent, biologically framed summary signal that helps contextualize longer-term change. Mental inconsistency as a motivational lever The compelling nature of biological age information stems from its capacity to generate mental inconsistency. This occurs when an individual holds two competing self-perceptions: their chronological age (“I am 45 years old and feel fine”) and their epigenetic age (“My body is functioning like a 60-year-old”). The variance between their personal reality and the objective biological data establishes considerable psychological tension. [15], [16] For some patients, that discrepancy may create enough psychological tension to increase attention, prompt reflection, and support consideration of behavior change. Nuance in interpretation It is essential to offer a full explanation of the elements shaping biological age to ensure accurate perception. While lifestyle choices are dynamic and readily adjustable, epigenetic age is also affected by inherent characteristics such as genetics, exposures in early life, and ancestral history. Health interventions can significantly alter the pace of aging (e.g., DunedinPACE [6]), but they may not entirely nullify long-term biological age acceleration caused by fixed factors. [3], [16], [17] Clinicians must define the objective as moderating the speed of biological aging and improving healthspan, rather than guaranteeing a simple, complete reversal of the current biological age figure. Integrating with the transtheoretical model Combining epigenetic age data with the Transtheoretical Model (TTM) offers a structured and personalized approach to guiding individuals toward lasting behavior change. The transtheoretical model consists of a circular complex of 6 stages of behavioral change: precontemplation, contemplation, preparation, action, maintenance, and relapse. [10], [12] Patients may progress through these stages at widely variable rates [13], but for lifestyle optimization, the action and maintenance stages are ideally what should be promoted by clinicians. By understanding an individual's current stage of change, clinicians can tailor interventions that are most likely to be effective. For example, individuals in the precontemplation stage, who are not yet considering behavior change, may be more receptive to information about the science of epigenetics and the concept of biological age to raise awareness, while those in the action stage may benefit from specific recommendations and strategies for maintaining their progress. The TTM, with its focus on progressing through stages of change, provides a framework for incorporating these personalized strategies. In this light, epigenetic age concepts and data can be sequentially presented strategically to create interest and positive outcomes in lifestyle medicine patient populations. Stagewise focus: Goals and strategies utilizing epigenetic concepts Each TTM stage represents a unique level of readiness and therefore requires a different communication task. In this framework, epigenetic age data is not presented identically at every stage. Instead, its role is adjusted according to patient readiness, emotional response, and the specific behavior being targeted. An interdisciplinary team may strengthen implementation by helping translate the biological information into concrete, behavior-specific plans, such as exercise progression, sleep optimization, nutrition change, or stress-management strategies. Because epigenetic age is complex and potentially emotionally charged information, clinicians should present it in clear language, with visual aids where appropriate, and explicit discussion of uncertainty and modifiability. [18], [19] In the precontemplation stage, the goal is not to persuade the patient to act immediately, but to raise awareness and curiosity. For a patient who is largely sedentary and not yet considering exercise, the clinician might introduce the idea that biological age can differ from chronological age and that behaviors such as physical inactivity, poor sleep, and chronic stress may influence the pace of aging. [1], [4], [17] At this stage, communication should remain nonjudgmental and educational. Rather than ordering testing immediately, the clinician can explain that epigenetic aging is potentially modifiable and use relatable examples to help the patient understand why lifestyle behaviors matter biologically. In the contemplation stage, patients are considering change but remain ambivalent. Here, epigenetic age feedback may be more useful because it can make abstract risk feel more personally relevant. For example, a patient with chronically short sleep duration who is uncertain whether behavior change is worthwhile may respond to a visual comparison between chronological age and epigenetic age, particularly if the result is framed as a modifiable signal rather than a fixed verdict. [2], [14] The clinician should pair disclosure with discussion of perceived barriers, benefits, and concerns, consistent with motivational interviewing principles. [20] The communication objective is to strengthen intrinsic motivation while avoiding shame, fatalism, or overinterpretation. In the preparation stage, patients are ready to make concrete plans. At this stage, epigenetic age can be used as a benchmark around which to organize realistic goals. For example, a patient who has decided to improve physical activity and sleep could work with the clinician to create SMART-EST goals, identify barriers, and choose practical monitoring tools such as step counts, exercise logs, or sleep tracking. [21], [22] Epigenetic age should be discussed as a longer-interval indicator that may or may not change quickly, whereas day-to-day progress is better captured by behavioral adherence and proximal metrics. This framing helps preserve motivation and prevents unrealistic expectations about immediate biological reversal. In the action stage, the main task is sustaining adherence and troubleshooting barriers. Patients actively changing behavior often benefit from frequent reinforcement, and this is where wearable data, self-monitoring, and coaching may play a larger role than repeat epigenetic testing. [22], [23], [24] For instance, a patient increasing weekly walking time and improving sleep regularity may use activity tracker feedback for short-term reinforcement, while the clinician uses epigenetic age as a broader biological context for why sustained adherence matters. Counseling should reinforce incremental gains, normalize imperfect progress, and adapt the plan when barriers arise. In the maintenance stage, the emphasis shifts from initiation to durability. Epigenetic age may be especially useful here as an intermittent feedback tool that reinforces the meaning of longer-term adherence rather than serving as a frequent monitoring instrument. A patient who has maintained regular exercise and improved sleep over several months may find repeat biological age assessment encouraging if results improve, but clinicians should prepare patients in advance for the possibility of modest or delayed change. Communication in this stage should frame healthy behavior as an ongoing practice, not a temporary intervention, and should include explicit planning for high-risk situations that could lead to slippage. [11] In the relapse prevention and re-engagement stages, the model departs most clearly from standard TTM applications. (See Fig. 1) Rather than waiting for full relapse, the clinician can use evidence of behavioral slippage, reduced self-monitoring, declining physical activity, or worsening sleep routines to trigger a structured reassessment. In selected cases, repeat epigenetic age testing may then be used as a higher-salience biological checkpoint to reinforce progress or support renewed effort. If the repeat result improves, the clinician can use that information to validate the patient's work. If it is unchanged or less favorable, the discussion should focus on interpretation, remaining uncertainty, and adjustment of the care plan rather than blame. This re-engagement loop is intended to return the patient to active behavior change while preserving self-efficacy and therapeutic alliance. Modified Transtheoretical model – Diversion 1. First pass relapse prevention. Repeat until optimization. Diversion 2. Second pass to identify new lifestyle targets, then return to Diversion 1. Discussion and conclusion Discussion The TTM offers a useful organizing framework for introducing epigenetic age feedback because it allows clinicians to match the intensity, timing, and purpose of biological information to a patient's readiness for change. In this model, epigenetic age is not treated as a superior replacement for established counseling tools, but as a potentially complementary source of information. Composite risk scores may remain more useful for disease-oriented risk stratification, while wearable and performance-based measures may be better suited for frequent reinforcement of specific behaviors. Epigenetic age may contribute a different kind of value by summarizing multisystem biological burden in a form that some patients find personally salient and easier to interpret. [4], [5], [22] If this model is used in practice, clinician-patient communication will be central to its success. Most clinicians are not currently trained to interpret or communicate epigenetic age results in a patient-centered way, and implementation would likely require education in biomarker interpretation, uncertainty communication, expectation setting, and behavior-change counseling. [18], [20] Results should be presented in plain language and framed as one potentially modifiable indicator rather than a deterministic forecast. Patients should also be told explicitly that behavioral progress can occur even when biological age results are stable, modest, or delayed, and that short-term adherence is better tracked by proximal measures such as activity logs, sleep metrics, symptom improvement, and functional change. [22], [23], [24] Communication practices used in genetic and biomarker risk disclosure are also relevant here. Patients are likely to benefit when complex results are contextualized, when uncertainty is acknowledged directly, and when interpretation is linked to a small number of achievable next steps rather than a broad set of vague lifestyle recommendations. [18], [19] Visual displays may help, but they should be accompanied by discussion that checks understanding, explores emotional reactions, and avoids shame-based framing. Teach-back, motivational interviewing, and interprofessional reinforcement may be especially useful when communicating epigenetic results because of the potential for misunderstanding, discouragement, or fatalistic interpretations. [18], [20] Important limitations remain. Epigenetic testing is still relatively expensive and often not covered by insurance, which raises equity concerns if it is proposed as part of routine counseling. Serial measurements may also be affected by technical variation, cell-type heterogeneity, and differences in analytic methods, making small changes difficult to interpret confidently. In addition, some patients may experience disappointment, anxiety, or disengagement if repeat results do not match their perceived effort. For those reasons, clinicians should avoid overpromising reversibility, emphasize health behavior change as beneficial even apart from clock movement, and obtain informed consent that includes discussion of uncertainty, privacy, and the still-evolving meaning of these data. [3], [16], [17] A logical next step is empirical testing. A small mixed-methods pilot study could evaluate feasibility, patient comprehension, clinician acceptability, emotional response, and preliminary behavior-change outcomes when stage-matched counseling is paired with epigenetic age disclosure. Such work could also compare epigenetic feedback–augmented counseling with usual counseling alone and help determine whether this model adds meaningful educational or motivational value beyond established tools. Innovation This article is innovative in two related ways. First, it reframes epigenetic age from a research-oriented biomarker into a patient education and counseling tool that may help translate biological risk into more concrete, behaviorally relevant conversations. Rather than treating epigenetic age as a stand-alone diagnostic endpoint, the model positions it within an established behavior-change framework and alongside other practical sources of feedback. Second, the article proposes a modified TTM in which repeat epigenetic assessment is used selectively during relapse prevention and re-engagement. This communication-oriented adaptation emphasizes when biological feedback may be most useful, how it should be contextualized, and how it might support renewed action without displacing established strategies such as motivational interviewing, self-monitoring, and interprofessional coaching. Conclusion Integrating epigenetic aging measures into a stage-matched TTM framework offers a plausible and patient-centered conceptual approach to health behavior counseling. The model may be especially useful when epigenetic age is presented as a complementary, intermittently used source of biological feedback rather than as a replacement for established risk metrics, self-monitoring tools, or performance measures. At present, however, the framework remains theoretical. Future work should test its feasibility, acceptability, communication effects, and incremental value in real-world clinical and lifestyle medicine settings. Declaration of generative AI and AI-assisted technologies in the manuscript preparation process During the preparation of this work the authors used Google Gemini 3 in order to edit and improve the flow of the completed article. After using this tool/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article. CRediT authorship contribution statement Phillip A. Williford: Visualization, Resources, Project administration, Data curation, Conceptualization, Writing – original draft. Dana Howell: Validation, Supervision, Writing – review & editing. Esther Dupont-Versteegden: Supervision, Writing – review & editing. Declaration of competing interest The authors have no competing interests. References